MustGrow Biologics Corp.
MGROF
$0.47
-$0.02-4.34%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -97.55% | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -97.55% | -- | -- |
| Cost of Revenue | 4,036.00% | 19,182.50% | 61.04% | 17.71% | -71.17% |
| Gross Profit | 809.65% | 2,775.83% | -100.79% | 359.96% | 71.17% |
| SG&A Expenses | 83.84% | 126.24% | -5.83% | 9.95% | -1.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 347.13% | 382.87% | 6.22% | 9.41% | -24.41% |
| Operating Income | -4.75% | -20.13% | -128.81% | 6.53% | 24.41% |
| Income Before Tax | -12.16% | -48.95% | -134.37% | 11.12% | 21.53% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.16% | -48.95% | -134.37% | 11.12% | 21.53% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.16% | -48.95% | -134.37% | 11.12% | 21.53% |
| EBIT | -4.75% | -20.13% | -128.81% | 6.53% | 24.41% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -11.03% | -41.22% | -133.53% | 14.03% | 24.44% |
| Normalized Basic EPS | -10.59% | -40.86% | -133.55% | 14.37% | 24.11% |
| EPS Diluted | -11.03% | -41.22% | -133.53% | 14.03% | 24.44% |
| Normalized Diluted EPS | -10.59% | -40.86% | -133.55% | 14.37% | 24.11% |
| Average Basic Shares Outstanding | 0.94% | 5.70% | 2.62% | 3.53% | 3.91% |
| Average Diluted Shares Outstanding | 0.94% | 5.70% | 2.62% | 3.53% | 3.91% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |